FOS was affirmed to be a target of miR-29b-3p, elevated expression of FOS reversed the inhibitory effects of miR-29b-3p on cell proliferation, migration, and differentiation in TGF-β1-activated CFs. The gene discussed is TGFB1; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.